Myriad Genetics (MYGN) Tops Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Myriad Genetics (MYGN) Tops Q1 EPS by 6c

Myriad Genetics (MYGN) PT Raised to $47 at Piper Jaffray

November 4, 2015 8:50 AM EST

Piper Jaffray analyst William Quirk reiterated an Overweight rating and boosted his price target on Myriad Genetics (NASDAQ: MYGN) to $47.00 (from $45.00) following Q1 beat.

Quirk commented, "Myriad's 1Q16 revenue increased 9% yoy to $183.5M, above consensus of $177.9M (PJC: $177.6M). Adjusted EPS of $0.41 was above consensus'... More

Myriad Genetics (MYGN) PT Lifted to $42 at Mizuho Securities Post Q1; Remains Sidelined

November 4, 2015 7:57 AM EST

Mizuho Securities analyst Eric Criscuolo bumped his price target on Myriad Genetics (NASDAQ: MYGN) to $42.00 (from $38.00) following results but remains on the sidelines with a Neutral rating.

Criscuolo commented, "We are upping our PT to $42 but remain on the sidelines. MYGN reported... More

Myriad Genetics (MYGN) PT Up to $46 at Leerink Partners After Solid Q1

November 4, 2015 7:21 AM EST

Leerink Partners analyst Dan Leonard lifted his price target on Myriad Genetics (NASDAQ: MYGN) to $46.00 (from $37.00) following solid Q1 results but maintained a Market Perform rating.

Leonard commented, "We are nudging up our FY16 estimates following MYGN's solid September quarter (F1Q),... More